Projects

Research Fellow
Ing. Danica Mihalová

National

Current
  • Pharmacological intervention in the treatment of cachexia by administering natural extracts (Crocus sativus and Ginkgo biloba) and substances (melittin, saffron, crocin, kaempferol and isorhamnetin) in combination with methotrexate and dexamethasone in an
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • The contribution of new nano-carrier drug delivery systems to the enhancement of the anti-inflammatory effect of D-limonene, phellandrene, isoborneol and chrysophanol studied in vivo (2/0091/23)
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
Finished
  • -
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • -
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2021
  • -
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • -
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Cellular and molecular aspects of pharmacological regulation of neutrophil pro-inflammatory activity
    Program: SRDA
    Duration: 9. 9. 2008 – 30. 6. 2011
  • Molecular mechanisms of new drugs influencing oxidative stress - important ethiopathogenetic factor of numerous diseases
    Program: SRDA
    Duration: 1. 9. 2006 – 31. 10. 2009
  • Effects of antioxidants and substances afecting the imunita systém studied in vivo using a model of adjuvant arthritis
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees